Clinical Trial Update: Non-Interventional Study on the Tolerability and Efficacy of IVIG

View source ↗

Summary

A completed non-interventional study evaluating tolerability and efficacy of Octagam IVIG in primary and secondary immunodeficiency and other conditions requiri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Octagam (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: Octapharma | Conditions: Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG | Status: COMPLETED | Results posted: 2021-06-29